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Sandra J. Sabbatini, MSN, RN-BC, CEN; Marna Rayl Greenberg, DO, MPH;
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ABSTRACT
Purpose: This study aimed to determine the current
attitudes, perceptions, and practices of emergency
medicine providers and nurses (RNs) regarding the
discharge of adult patients from the emergency department (ED) after administration of opioid analgesics.
Methods: A cross-sectional survey was administered at 3 hospital sites with a combined annual ED
census of 4180,000 visits per year. All 59 attending
emergency physicians (EPs), 233 RNs, and 23 advanced practice clinicians (APCs) who worked at these
sites were eligible to participate.
Findings: Thirty-ﬁve EPs (59.3%), 88 RNs
(37.8%), and 14 APCs (60.9%) completed the survey
for an overall response rate of 51.75%. Most respondents were female (95 [69.9%]). The factor
ranked most important to consider when discharging
a patient from the ED after administration of opioids
was the patient’s functional status and vital signs
(median, 2.00; interquartile range, 2.00–3.50). More
RNs (84 [96.6%]) than EPs (29 [82.9%]) reported
that developing an ED policy or guideline for safe
discharge after administration of opioids is important
to clinical practice (P ¼ 0.02). Only 8 physicians
(23.5%) reported that they did not prescribe intramuscular morphine, and 15 (42.9%) reported that
they did not prescribe intramuscular hydromorphone.
EPs (7 [20.0%]) and RNs (3 [3.4%]) differed in regard
to whether they were aware if any patients to whom
they administered an opioid had experienced an
adverse drug-related event (P ¼ 0.01). Most EPs (24
[68.6%]) and RNs (54 [61.4%]) believed that the
decision for patient discharge should be left to both
the emergency medicine provider and the RN.

214

Implications: Most study participants believed that
developing a policy or guideline for safe discharge
after administration opioids in the ED is important to
clinical practice. Only a few physicians reported that
they did not prescribe intramuscular hydromorphone
or morphine. Most participants believed the discharge
decision after administration of opioids in the ED
should be primarily determined by both the emergency medicine provider and the RN. (Clin Ther.
2018;40:214–223) & 2018 Elsevier HS Journals, Inc.
All rights reserved.
Key words: analgesics, opiate, opioid, safe
discharge.

INTRODUCTION
In the United States, approximately 105 people die of
drug exposures on a daily basis.1 More than 2 million
emergency department (ED) visits annually result
from drug misuse and abuse.1 Drug-related deaths
due to prescription analgesics such as opioids have
now surpassed trauma as the leading cause of injury
deaths.2 In 2012, a total of 2937 cases of fatal
poisonings were reported to the National Poison
Data System; the primary substance implicated was
a pharmaceutical.3 Of these, abused prescription
drugs, primarily opioids, were implicated, including
methadone, oxycodone, acetaminophen/hydrocodone,
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morphine, fentanyl, tramadol, and oxycodone/
acetaminophen.3 Even worse, the drug-related death
rates are increasing; they have nearly quadrupled since
1999.4
According to the Agency for Healthcare Research
and Quality, the problem has become much broader,
with hospitalizations increasing among middle-aged
and older age groups.5 In addition, there has been a
signiﬁcant increase in both pain-related US ED visits
and prescriptions for opioid analgesics during the past
decade.6 Between 2001 and 2010, Mazer-Amirshahi
et al6 noted hydromorphone and oxycodone had
the greatest increase in ED administration, and
oxycodone and hydrocodone had the largest
increases in discharge prescriptions. Interestingly,
there was no difference in discharge prescriptions for
nonopioid analgesics during the same period.6 In a
recent study of 27,516 ED patient visits during a
single week across the country, 17% of discharged
patients were prescribed opioid pain relievers.7
Coupled with these increases in prescription use
and misuse, iatrogenic injury due to opioid analgesic
administration in the ED has recently been examined.
In 2015, Beaudoin et al8 identiﬁed 73 ED patients
in 2 urban academic EDs in which naloxone
administration was required because of iatrogenic
overdose after opioid administration. Patient-,
provider-, and systems-based risk factors included
chronic medical conditions; failure to adjust dosing
in the elderly, and renal and hepatic impairment;
multiple doses and routes of administration; coadministration of sedatives; problems with patient
hand-offs; consideration of patient sex; and
pharmacy error.8 In 2012, the Joint Commission
recommended initiating policies and procedures for
reducing adverse events with opioids for inpatients,
yet interestingly it failed to speciﬁcally address the
subset of patients who receive opioids in the ED and
are then discharged.9
Intriguingly, the postanesthesia care unit has similar features to the ED in terms of treating acute pain
with subsequent discharge, along with the potential
for opioid-associated adverse drug events. General
guidelines and recommendations for discharge of the
postoperative patient after opioid administration have
existed for the postanesthesia care unit, unlike the ED,
by groups, including the American Society of Perianesthetic Nurses (Appendix I) and the American
Society of Anesthesiologists.10 The American Society

of Perianesthetic Nurses has recommended a more
speciﬁc time frame by which to discharge the
postoperative patient based on pharmacokinetic
parameters.10 The American Society of Anesthesiologists has not recommended a mandatory
observation period after medication administration
but instead has recommended that “patients should
be observed until they are no longer at risk for
cardiorespiratory depression and discharge criteria
should be designed to minimize the risk of central
nervous system or cardiorespiratory depression after
discharge.”11 Clearly, both organizations addressed
the issue of patient discharge after opioid
administration, albeit in a slightly different manner.
Other often overlooked yet signiﬁcant problems
associated with patients receiving opioid medications
in the ED and subsequently being discharged (with or
without prescriptions) include falls and impairment
while performing complex motor tasks.12 McIntosh
and Lefﬂer13 noted that 7% of patients who received
opioid analgesics after discharge from the ED “drove
a vehicle while under the inﬂuence of the drug.” In
addition, sex-speciﬁc guidelines for patient discharge
have not been developed, a particular gap in the
scientiﬁc literature because sex-speciﬁc differences in
drug ofﬂoading (eg, males have a more rapid onset
and offset of morphine than females) have been
documented.14
Regarding these clear deﬁciencies in the ED discharge process after opioid administration, Wolf
et al15 recently published a survey of emergency
nurses (RNs) that revealed the perception that
determination of readiness for discharge after a
patient has received Schedule II or III narcotics in
the ED is largely left up to the nursing staff.
Participants suggested that development of policies
and checklists to assist in decision making related to
discharge readiness would be useful for both RNs and
patients.15
We hypothesized that there would be signiﬁcant
variability among perceptions and practices regarding
discharging ED patients after opioid administration
among emergency medicine (EM) clinical care providers. This study aimed to determine the current
attitudes, perceptions, and practices of attending
emergency physicians (EPs), physician assistants
(PAs), nurse practitioners (CRNPs), and RNs regarding the discharge of adult patients after administration
of opioid analgesics.

February 2018
Downloaded for library services (libraryservices@lvhn.org) at Lehigh Valley Health Network from ClinicalKey.com by Elsevier on
August 24, 2022. For personal use only. No other uses without permission. Copyright ©2022. Elsevier Inc. All rights reserved.

215

Clinical Therapeutics

METHODS
After institutional review board approval, a crosssectional survey (Appendix II) was administered to
staff at 3 network hospital sites in northeastern
Pennsylvania with a combined annual ED census of
4180,000 visits per year. The network provides care
at these clinical sites, 2 of which are suburban
campuses and 1 an inner-city facility. One of the
suburban sites hosts an afﬁliated 4-year EM residency
program. For data analysis purposes, PAs and CRNPs
who responded were combined into an advanced
practice clinician (APC) group. All EM attending
physicians, APCs, and RNs who worked at any of
the network’s 3 sites were eligible to participate.
A survey was developed by the study team. The
face validity of the survey was assessed by approximately 15 senior residents (postgraduate year 4) at
the network and APCs and RNs from nearby hospitals. These respondents’ answers were not included in
the analysis data set. After minor clerical and grammar changes were made, the survey was prepared for
distribution. An email that explained the study’s
objective and procedures, that recipient response was
voluntary and part of a research study, and with an
embedded link to an online survey via Survey Monkey
was sent to all eligible study participants. This selfadministered survey consisted of 23 multiple choice
questions and took approximately ≤15 minutes to
complete. Study participants were sent 2 reminder
emails, approximately 2 weeks apart, as a follow-up
to ensure as high a response rate as possible.
Response rates were calculated based on the American Association for Public Opinion Research standard deﬁnitions (2016).16 Questions 3 and 19 were
excluded from the response rate calculation because
these were qualitative answer responses that further
described a prior question. Question 1 was counted as
complete as long as the respondent ranked one of the
factors. The calculation method used included partial
responses, which were counted as responses to the
survey.
Descriptive statistics were used to summarize the data
and presented by group based on whether the respondent was an EP, APC, or RN. For analysis purposes, PAs
and CRNPs were combined into the APC category
because the number of respondents in each category
was very small (12 and 2, respectively). Because of the
small number of APCs, the analysis of their responses
was restricted to descriptive statistics only.
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Because all the questions were categorical, numbers
and percentages were calculated for each response to
each question. The χ2 test for independence was used
to assess for any statistically signiﬁcant differences
between the physicians and RNs. If any of the
expected data cell counts were o5, the Fisher exact
test was used instead.
To test our hypothesis, questions 2, 3, 14, 15, 16,
17, and 18 were analyzed to determine whether
perceptions were different between the 2 groups, and
questions 1, 4, 5, 6, 7, 8, 9, 10, 11, 12, and 13 were
used to assess whether actual practice was different
between the 2 groups. P o 0.05 was considered
statistically signiﬁcant, and all tests were 2-tailed.
SAS software, version 9.3 2 (SAS Institute, Cary,
North Carolina) was used for the analysis.

RESULTS
Fifty-nine attending, board-certiﬁed/board-eligible
EPs, 233 emergency RNs, and 23 APCs who worked
at the 3 sites were approached to participate in the
survey. A total of 163 respondents took the survey for
an overall response rate of 51.7%. Speciﬁc response
rates by credentials were as follows: 59.3% (n ¼ 35)
for EPs, 37.8% (n ¼ 88) for RNs, and 60.9% (n ¼ 14)
for APCs. Most participants were female (95
[69.9%]). Only 10 participants (7.3%) were 18
through 24 years old, 34 (24.8%) were 25 through
30 years old, 41 (29.9%) were 31 through 40 years
old, 32 (23.4%) were 41 through 50, years old and
the remaining 20 (14.6%) were 451 years old.
Regarding years of experience since professional
health care graduation, 54 (39.1%) participants had
410 years, 34 (24.6%) had 45 to 10 years, 43
(31.2%) had 1 to 5 years, and only 7 (5.1%) had o1
year. Table I gives a breakdown of the demographic
characteristics by credentials.
A statistically signiﬁcant difference in age was found
between physicians and RNs (P o .01); RNs tended to
be younger than the EPs. A statistically signiﬁcant
difference in sex was found between physicians and
RNs. Most physicians were male (23 [65.7%]), whereas
most RNs were female (72 [82.8%]) (P o .01). In
addition, the physicians appeared to have more
clinical experience since graduation (21 [60.0%] with
410 years) than the nurses (27 [30.7%] with 410
years). This difference in experience was also statistically signiﬁcant (P ¼ 0.01).
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Table I. Patient demographic characteristics by credentials.
Characteristic

APCs (n ¼ 14)

Age group, y
18–24
25–30
31–40
41–50
451
Sex
Male
Female
Experience, y
o1
1–5
45–10
410

Physicians (n ¼ 35)

RNs (n ¼ 88)

P (Comparison of
Physicians and RNs)
o0.01

0
7
3
2
1

(0.0)
(53.9)
(23.1)
(15.4)
(7.7)

0
0
10
16
9

(0.0)
(0.0)
(28.6)
(45.7)
(25.7)

10
27
28
14
9

(11.4)
(30.7)
(31.8)
(15.9)
(10.2)
o0.01

3 (23.1)
10 (76.9)

23 (65.7)
12 (34.3)

15 (17.2)
72 (82.8)

0
4
10
21

6
34
21
27

o0.01
1
5
3
5

(7.1)
(35.7)
(21.4)
(35.7)

(0.0)
(11.4)
(28.6)
(60.0)

(6.8)
(38.6)
(23.9)
(30.7)

APCs ¼ advanced practice clinicians; RNs ¼ nurses.

Perception Questions
The factor ranked most important to consider
when discharging a patient from the ED after administration of opioids was the patient’s functional status
and vital signs in the ED (median, 2.00; interquartile
range, 1.00–4.00). The factor ranked least important,
excluding the “other” answer option, was time of day
(median, 7.00; interquartile range, 5.00-7.00). Most
of the EPs (18 [51.4%]) and RNs (38 [43.2%])
thought that the existing discharge decision after a
patient was administered an opioid was left up to both
the EM provider (EP, PA, or CRNP) and the RN,
whereas 14 EPs (40.0%) and 35 RNs (39.8%) said it
was left up to the EM provider alone. Only 3 EPs
(8.6%) and 15 RNs (17.1%) thought it was left solely
up to the RN. These differences were not statistically
signiﬁcant (P ¼ 0.45).
Responses to the question regarding who respondents believed should be responsible for a patient’s
discharge after receiving opioids in the ED followed a
similar pattern. Most EPs (24 [68.6%]) and RNs (54
[61.4%]) thought the decision should be left to both
the EM provider and the RN, 10 EPs (28.6%) and 28
RNs (31.8%) thought it should be solely up to the EM
provider, and only 1 EP (2.9%) and 6 RNs (6.8%)
thought it should be left to only the nurse. Again,

these differences were not statistically signiﬁcant
(P ¼ 0.61).
A slightly larger percentage of EPs (11 [31.4%])
compared with RNs (18 [20.7%]) were aware of
any national clinical policies or guidelines that
addressed safe discharge from the ED after administration of opioids, but this difference lacked statistical signiﬁcance (P ¼ 0.21). There was a
statistically signiﬁcant difference between EPs and
RNs regarding the perception that developing a
policy or guideline for safe discharge after opioid
administration is important to clinical practice (P ¼
0.02). Although 84 RNs (96.6%) thought this was
important, only 29 EPs (82.9%) thought this. There
was also a statistically signiﬁcant difference between
EPs (7 [20.0%]) and RNs (3 [3.4%]) regarding
whether they were aware of any patients to whom
they had administered an opioid who experienced an
adverse drug-related event (P ¼ 0.01). Table II
contains a list of all responses to perception-related
questions by credentials.

Practice Questions
With regard to clinical practice, a statistically
signiﬁcant difference was found in the administration
of intramuscular hydromorphone between EPs and
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Table II. Perception survey responses by credentials.
No. (%) of Respondents
Question
Difference between orally, intravenously,
and intramuscularly administered
opioids in terms of discharging a patient
from the ED
Aware of any national, clinical policies or
guidelines addressing safe discharge
from the ED after administration of
opioids
Developing a policy or guideline for safe
discharge after administration of opioids
in the ED is important to clinical practice
Current discharge decision after
administration of opioids in the ED is
primarily left to
Provider (physician, physician
assistant, or nurse practitioner)
RN
Both
Responsibility to whom discharge after
administration of opioids in the ED
should be left
Provider (physician, physician
assistant, nurse practitioner)
RN
Both
Aware of any patient to whom you
administered an opioid during ED visit
and then was discharged and
experienced an adverse drug-related
event

APCs
(n ¼ 14)

Physicians
(n ¼ 35)

RNs
(n ¼ 88)

P (Comparison
of Physicians
and RNs)

11 (78.6)

28 (80.0)

69 (78.4)

0.85*

5 (35.7)

11 (31.4)

18 (20.7)

0.21*

14 (100.0)

29 (82.9)

84 (96.6)

0.02†

0.45*

4 (28.6)

14 (40.0)

35 (39.8)

0 (0.0)
10 (71.4)

3 (8.6)
18 (51.4)

15 (17.1)
38 (43.2)
0.61*

5 (35.7)

10 (28.6)

28 (31.8)

0 (0.0)
9 (64.3)
2 (14.3)

1 (2.9)
24 (68.6)
7 (20.0)

6 (6.8)
54 (61.4)
3 (3.4)

0.01†

APCs ¼ advanced practice clinicians; ED ¼ emergency department; RNs ¼ nurses.
⁎
Calculated using the χ2 test.
†
Calculated using the Fisher exact test.

RNs (P ¼ 0.01). More EPs (15 [42.9%]) than RNs (16
[18.4%]) responded that they do not prescribe or
administer intramuscular hydromorphone. On discharge of a patient, who not only received opioids in
the ED but was given a prescription for them, a
greater number of RNs (85 [96.6%]) than EPs (28

218

[80.0%]) indicated they routinely provide instructions
for when to take the next dose (P ¼ 0.01). There was
a lack of consensus between EPs and RNs (P ¼ 0.03)
as to how long a patient should wait to take the ﬁrst
opioid dose after discharge. Half (14 [50.0%]) of the
EPs stated they tell a patient to take the ﬁrst dose after
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Table III. Practice survey responses by credentials.
No. (%) of Respondents
APCs
(n ¼ 14)

Question
On average, how long do you wait before
discharging patients after
administration of…
Intramuscular hydromorphone
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame
I do not prescribe or administer this
medication
Intravenous hydromorphone
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame
I do not prescribe or administer this
medication
Intramuscular morphine
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame
I do not prescribe or administer this
medication
Intravenous morphine
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame
I do not prescribe or administer this
medication
Intravenous fentanyl
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame

Physicians
(n ¼ 35)

RNs (n ¼ 88)

P (Comparison
of Physicians
and RNs)

0.01*
0
3
0
0
1
10

(0.0)
(21.4)
(0.0)
(0.0)
(7.1)
(71.4)

2
1
8
4
5
15

(5.7)
(2.9)
(22.9)
(11.4)
(14.3)
(42.9)

5
23
18
13
12
16

(5.8)
(26.4)
(20.7)
(14.9)
(13.8)
(18.4)
0.18*

0
2
4
0
3
5

(0.0)
(14.3)
(28.6)
(0.0)
(21.4)
(35.7)

0
5
14
7
6
3

(0.0)
(14.3)
(40.0)
(20.0)
(17.1)
(8.6)

2
19
24
27
15
1

(2.3)
(21.6)
(27.3)
(30.7)
(17.1)
(1.1)
0.20*

1
3
1
0
2
6

(7.7)
(23.1)
(7.7)
(0.0)
(15.4)
(46.2)

2
4
11
5
4
8

(5.9)
(11.8)
(32.4)
(14.7)
(11.8)
(23.5)

4
26
24
9
15
10

(4.6)
(29.6)
(27.3)
(10.2)
(17.1)
(11.4)
0.81†

0 (0.0)
6 (42.9)
3 (21.4)
2 (14.3)
3 (21.4)
–

1 (2.9)
9 (25.7)
14 (40.0)
7 (20.0)
4 (11.4)
–

3 (3.5)
25 (28.7)
25 (28.7)
20 (23.0)
14 (16.1)
–
0.30*

0
5
3
1
3

(0.0)
(35.7)
(21.4)
(7.1)
(21.4)

3
15
9
5
3

(8.6)
(42.9)
(25.7)
(14.3)
(8.6)

2
30
28
10
16

(2.3)
(34.9)
(32.6)
(11.6)
(18.6)
(continued)
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Table III. (continued).
No. (%) of Respondents
Question
I do not prescribe or administer this
medication
Oral opiates or opioids
0–30 min
31–60 min
61–120 min
4120 min
I do not use any speciﬁc time frame
I do not prescribe or administer this
medication
If patient is administered opiates or
opioids in ED and prescribed opiates
or opioids at discharge, do you
routinely provide instructions when to
take next dose?
How long do you tell patient to wait
before taking ﬁrst dose?
Within 2 hours of discharge
After 2 hours but before 4 hours
after discharge
After 4 hours but before 6 hours
after discharge
After 6 hours after discharge
Other
Do you routinely consider whether
patient is opiate/opioid naive on
prescription or administration of
opiates or opioids in the ED?
Does your ED limit the total number of
opiates or opioids a patient receives in
the ED?

APCs
(n ¼ 14)

Physicians
(n ¼ 35)

RNs (n ¼ 88)

2 (14.3)

0 (0.0)

0 (0.0)

P (Comparison
of Physicians
and RNs)

0.46†
7 (50.0)
3 (21.4)
1 (7.1)
0 (0.0)
3 (21.4)
–

10 (28.6)
5 (14.3)
9 (25.7)
3 (8.6)
8 (22.9)
–

26 (29.6)
21 (23.9)
12 (13.6)
11 (12.5)
18 (20.5)
–

11 (78.6)

28 (80.0)

85 (96.6)

0.01*

0.03*
0 (0.0)
1 (9.1)

1 (3.6)
3 (10.7)

3 (3.6)
1 (1.2)

5 (45.5)

14 (50.0)

25 (30.1)

5 (45.5)
0 (0.0)
11 (78.6)

5 (17.9)
5 (17.9)
34 (97.1)

21 (25.3)
33 (39.8)
76 (86.4)

0.11*

3 (21.4)

5 (14.3)

26 (29.6)

0.08†

APCs ¼ advanced practice clinicians; ED ¼ emergency department; RNs ¼ nurses.
⁎
Calculated using the Fisher exact test.
†
Calculated using the χ2 test.

4 hours but before 6 hours, whereas only 25 RNs
(30.1%) did so. More RNs (33 [39.8%]) than the EPs
(5 [17.9%]) responded “other” for this same question.
Table III contains a list of all the practice-related
questions and participant responses by credentials.
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DISCUSSION
Although variability was present among the sampling
of EM providers, several themes were apparent. Most
EM providers thought that developing a policy or
guideline for safe discharge after administration of
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opioids in the ED was important to clinical practice.
With statistical signiﬁcance, more RNs than EPs
thought that developing a policy or guideline was an
important goal. This is especially curious because, in
contrast and with statistical signiﬁcance, more EPs
than RNs reported being aware of a patient who had
received these medications, been discharged, and had
experienced an adverse drug-related event. In addition, although EPs were more likely to be aware of
adverse events, only a few of them reported that they
did not prescribe intramuscular hydromorphone or
morphine. This is despite the fact it is recognized and
credibly reported that the intramuscular route has
several disadvantages, is not the best choice from a
patient tolerability perspective, and is not recommended for pain management in the ED.17
Speciﬁcally, the signiﬁcant disadvantages of intramuscular opioid administration include unreliable
onset of action, unpredictable effect, and inability to
titrate dosing.17 Although some factors that increase
patients’ risk of harm include older age (ie, ≥65 years
of age), diseases that affect the respiratory system
(eg, asthma, chronic obstructive pulmonary disease)
or cardiovascular system, concomitant use of
respiratory-function depressants other than opioids,
opioid-naive patients who are overweight, and
patients with sleep disorders (eg, sleep apnea),18
there are no reliable pharmacokinetic data regarding
intramuscular opioids and adverse events in the ED
setting. Given these unpredictable and potentially
dangerous problems and obviation with the more
consistent and predictable effects of oral or
intravenous administration, intramuscular opioid
administration route should simply be avoided in
the ED. Our study’s ﬁndings suggest there is an
opportunity for improvement in this unwise clinical
practice habit.
In consideration of observation use after medication dosing, there were differences in EM provider
responses. For instance, respondents seemed to have
reasonable approaches of waiting some time before
discharge and waiting additional time (most commonly 4–6 hours) after discharge before initiating
the patient’s ﬁrst dose of opioid prescription medications. The patient’s functional status in the ED was
ranked as the most important factor in determining
readiness for discharge. It is reassuring that team
members recognize the importance of functional

status, especially considering in the United States falls
are the leading cause of injury and death for older
adults; the link between use of sedating medications
and falls is readily apparent.19 Most practitioners
believed that the discharge decision and the
responsibility
for
discharge
after
opioid
administration should be primarily determined by
both the EM provider and the RN. This ﬁnding is
further reassuring because in a culture of patient
tolerability, this kind of team approach is ideal.20
We believe that adverse drug reactions that involve
opioids after ED discharge are likely underreported. A
possible explanation of the apparent discrepancy
between RN and physician responses to support for
guideline development and knowledge of adverse drug
reactions may be at least in part attributable to the
differences in survey response rates between groups,
the relatively small numbers, and possibly the different roles RNs and physicians play in the care of
their patients.
This survey complements other recently published
work21–23 and leads the way for future research that
might include broadening the data pool and considering such responses at other institutions. More in-depth
queries moving forward in this content area might also
explore why the differences we found existed. Our
ﬁndings are a logical ﬁrst step to developing a clinical
guideline or policy to help EPs and RNs determine the
best and most appropriately safe discharge plan in the
ED setting. Generally speaking, moving forward,
authors would recommend key stakeholder meetings
to develop consensus on a guideline. Undoubtedly, it
would include basic constructs used by the American
Society of Perianesthetics Nurses10 and incorporate
key strategies, such as avoiding intramuscular and
subcutaneous administration of these medications,
appropriate timing recommendations considering
concomitant medication use, and time of day that
discharge occurred.

LIMITATIONS
This study was performed at a single network of
hospitals in Northeastern Pennsylvania, and the results may not be geographically generalizable. In
addition, a sex-speciﬁc analysis was not performed
in this study. Sex of the respondent was statistically
signiﬁcantly associated with position, so sex-speciﬁc
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analysis would have needed to take job position into
account. Unfortunately, the cell sizes for position,
broken down by sex, were too small to report
conﬁdent results. A more robust sample size in which
a greater number of male RNs and female physicians
were surveyed would have allowed for this type of
analysis and is an opportunity for future research. The
small sample size might have limited the project’s
validity and the fact that we did not collect attitudes in
correlation with the diagnosis of a visit. Although we
queried responses related to the timing of medication
administration, this alone may not be the only
independent feature of the discharge process, and the
effect of other considerations cannot be identiﬁed.
Furthermore, although authors express concern regarding the intramuscular route disadvantages, riskof-harm factors, lack of reliable pharmacokinetic
data, and the suggestion of an opportunity for
improvement, they recognize that the supporting data
to make this a well-supported recommendation are
not available.
In addition, the results represent only the views of
those who were willing to take the voluntary survey.
The response rate of the survey was less than optimal;
opinions of those who did not respond cannot be
assessed, and it is unclear what effect this potential
nonresponse bias may have had on the results.

CONCLUSIONS
Most study participants believed that developing a
policy or guideline for safe discharge after administration of opioids in the ED is important to clinical
practice. Only a few physicians reported they did not
prescribe intramuscular hydromorphone or morphine.
A patient’s functional status in the ED was ranked as
the most important factor in determining readiness for
discharge. Most participants believed the discharge
decision and responsibility for discharge after opioid
administration should be primarily determined by
both the EM provider and the RN.
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SUPPLEMENTARY MATERIAL
Appendix 1. American Society of Perianesthetic
Nurses’ Narcotic Administration Guidelines10
When evaluating a patient for discharge from Phase
I or Phase II after a narcotic, several factors need to be
kept in mind. These factors include what is the dosage,
what is the route, what is the onset of action, when
does the medication’ peak, what is the duration of the
medication, and what is the half-life of the medication.1–3
With IV medications, obviously there is a quicker
onset and a shorter duration of action. Most IV
medications, including Morphine, Dilaudid, and Fentanyl, have an onset of action of 1-5 minutes and peak
within 5-20 minutes. The duration of action with
Morphine and Dilaudid is 2-4 hours, while the
duration of action of Fentanyl is 30 minutes to 1
hour. Morphine and Fentanyl have a half-life of 3-4
hours, while Dilaudid has a half-life of 2 hours.1–3
Oral narcotics have an onset of 30-60 minutes, and
peak in 60-90 minutes.1–3
With this information in mind, the nurse must
consider what is safe in terms of when the patient
can transition to the next level of care. Since IV
medications peak in 5-20 minutes, it is prudent for
the nurse to use this interval to assess the patient for
adverse respiratory effects. The nurse should also
monitor the patient without any stimulation to determine how the patient may respond when moved to a
quiet patient room without the added PACU environmental stimuli. Patients will generally desaturate when
unstimulated. Ensuring that the patient can handle a
narcotic without episodes of oxygen desaturation is a
key to determining when it is safe to discharge/transfer
a patient.
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With oral narcotics, the nurse should ask the
patient if he has taken the medication previously
and if it was effective. If yes, the nurse can give the
patient the narcotic with relative assurance that the
patient will not suffer adverse effects and that it will
provide pain relief. If the patient has not received the
oral narcotic previously, the nurse can give it shortly
before transitioning to Phase II. This allows time for
the narcotic to take effect over 30-60 minutes and
time for the nurse to evaluate the patient’s response.
So with this information in mind, what is the time
frame for discharge after narcotics? Since most IV
narcotics peak in 20 minutes, 30 minutes should allow
sufﬁcient time to observe for adverse respiratory
effects. Waiting 30 minutes is generally a safe post
administration interval before discharge from Phase I.
With oral narcotics, the nurse can observe for effectiveness within 30-60 minutes of administration and
the patient can transition home. These time frames
allow the patient to progress to the next phase of care
in a safe and effective manner.

Appendix 2 Survey Instrument Safe Discharge
Survey
Perception and Practice among Emergency Medicine Healthcare Providers regarding Discharging Patients after Opiate or Opioid Administration (Active
Survey)
Please help us by completing the following "Safe
Discharge Survey;" your feedback is critical and
needed by June 30th. Any questions you may have
about this process may be directed to (blinded) for
peer review. Thank you so much for your help!
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1) Which of the following factors do you considermost important when discharging a patient from the ED after
administration of opiates or opioids? Rank from most important (#1) to least important (#7). You may rank all 8 if
“Other” is used.

RANKING

a. Pharmacokinetics

_______

b. Functional status and vital signs in the ED

_______

c. Response to the medication

_______

d. Social support (e.g., ride home, available caregivers)

_______

e. Time of day

_______

f.

_______

Co-morbidities

g. Age

_______

h. Other, please describe: ____________________________ _______
2)

Do you feel there is a difference between orally-, intravenously-and intramuscularly-administered opiates or
opioids in terms of discharging a patient from the ED?
a. Yes
b. No

3) What do you feel is the difference?
Please describe: _________________________________________________________

4) On average, how long do you wait before discharging patients after administration of intramuscular (IM)
hydromorphone?
a. 0-30 minutes
b. 31-60 minutes
c. 61-120 minutes
d. >120 minutes
e. I do not use any specific timeframe
f.

I do not prescribe or administer this medication

5) On average, how long do you wait before discharging patients after administration of intravenous (IV)
hydromorphone?
a. 0-30 minutes
b. 31-60 minutes
c. 61-120 minutes
d. >120 minutes
e. I do not use any specific timeframe
f.

I do not prescribe or administer this medication

6) On average, how long do you wait before discharging paents aer administraon of intramuscular (IM)
morphine?
a. 0-30 minutes
b. 31-60 minutes
c.

61-120 minutes

d. >120 minutes
e. I do not use any speciﬁc meframe
f.

I do not prescribe or administer this medicaon

7) On average, how long do you wait before discharging paents aer administraon of intravenous (IV) morphine?
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a. 0-30 minutes
b. 31-60 minutes
c.

61-120 minutes

d. >120 minutes
e. I do not use any speciﬁc meframe
f.

I do not prescribe or administer this medicaon

8) On average, how long do you wait before discharging paents aer administraon of intravenous (IV) fentanyl?
a. 0-30 minutes
b. 31-60 minutes
c.

61-120 minutes

d. >120 minutes
e. I do not use any speciﬁc meframe
f.

I do not prescribe or administer this medicaon

9) On average, how long do you wait before discharging paents aer administraon of oral opiates or opioids (e.g.,
oxycodone, hydrocodone, tramadol, codeine)?
a. 0-30 minutes
b. 31-60 minutes
c.

61-120 minutes

d. >120 minutes
e. I do not use any speciﬁc meframe
f.

I do not prescribe or administer these medicaons

10) If a paent is administered an opiate or opioid in the ED and then is prescribed opiates or opioids at the me of
discharge, do you rounely provide instrucons regarding when the next dose should be taken?
a. Yes
b. No

11) How long would you tell the patient to wait before taking the first dose?
a. Can take first dose immediately (<2 hours) post discharge
b. Can take first dose after 2 hours, but prior to 4 hours post discharge
c. Can take first dose after 4 hours, but prior to 6 hours post discharge
d. Can take first dose after 6 hours post discharge
e. Other, please describe: _________________________________________
12) Do you routinely consider if the patient is opiate/opioid naïve upon prescription or administration of opiate or
opioids in the ED?
a. Yes
b. No
13) Does your ED limit the total number of opiate or opioid administrations a patient receives in the ED?
a. Yes
b. No
14) Are you aware of any national, clinical policies or guidelines that currently exist addressing the issue of safe
discharge from the ED after administration of opiates or opioids?
a. Yes
b. No
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15) Do you feel that developing a policy or guideline for the safe discharge of patients after administration of opiates
or opioids in the ED is important to clinical practice?
a. Yes
b. No
16) Do you feel that the current patient discharge decision after administration of opiates or opioids in the ED is
primarily left to the:
a. Provider (Physician/Physician’s Assistant/Nurse Practitioner)
b. Nurse
c. Both
17) Who do you feel should be responsible for the discharge of apatient after administration of opiates or opioids in
the ED?
a. Provider (Physician/Physician’s Assistant/Nurse Practitioner)
b. Nurse
c. Both
18) Are you aware of anypatient to whom you administered an opiate or opioid during the ED visit,and then was
discharged and experienced an adverse drug event attributed to these medications?
a. Yes
b. No

19) Briefly describe what happened:
_________________________________________________________________________
20) What is your age?
a. 18-24
b. 25-30
c. 31-40
d. 41-50
e. >51
21) What is your sex?
a. Male
b. Female
22) How many years has it been since completion of your residency or graduation from nursing school?
a. <1 year
b. 1-5 years
c. >5 years-10 years
d. >10 years
23) Are you a physician or a nurse?
a. Physician
b. Physician’s Assistant
c. Nurse Practitioner

d. Registered Nurse
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